MedTrace Logo

Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

NCT05100563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2022-05-11

No results posted yet for this study

Summary

High dose naltrexone with response gauged by pain tolerance as measured by the cold pressor test may help treat autism.

Conditions

Interventions

DRUG

50 mg naltrexone

Medication combined with twice a week psychotherapy

Sponsors & Collaborators

  • State University of New York - Upstate Medical University

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2021-05-24
Completion
2021-05-24
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100563 on ClinicalTrials.gov